SBSiobhan Botwright

Siobhan Botwright

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Siobhan Botwright has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Which good practice exists for policymaking under uncertainty? An interdisciplinary review with relevance for health technology assessment (HTA)

    by Siobhan Botwright, Itamar Megiddo, Yot Teerawattananon, Tanainan Chuanchaiyakul, John Quigley, Abigail Colson

  • Open Access

    Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings

    by Siobhan Botwright, Syarifah Liza Munira, Itamar Megiddo, Nouran El Desouky, Lucky Gift Ngwira, Hugo C. Turner, Yot Teerawattananon


  • Open Access

    The path to safe, equitable and sustainable dialysis provision for people with chronic kidney disease

    by Yot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, Jiratorn Sutawong, Natcha Yongphiphatwong, Natasha Chawla, Siobhan Botwright, Tanainan Chuanchaiyakul, Thunyarat Anothaisintawee, Fatiu Arogundade, et al.

  • Top Cited Papers

    Nature Medicine Commission on dialysis policy in low- and middle-income countries

    by Yot Teerawattananon, Kinanti Khansa Chavarina, Jeerath Phannajit, Jiratorn Sutawong, Natcha Yongphiphatwong, Natasha Chawla, Siobhan Botwright, Tanainan Chuanchaiyakul, Thunyarat Anothaisintawee, Fatiu Arogundade, et al.

    The global demand for kidney replacement therapy (KRT) continues to increase, yet access remains limited in many low- and middle-income countries. Thailand has been recognized for integrating a sustainable KRT delivery model into its Universal Health Coverage scheme through a peritoneal dialysis–first (‘PD-First’) policy adopted in 2008. In 2022, the policy was revised to allow individuals to choose between hemodialysis or peritoneal dialysis as their first-line treatment. The intention was to improve patient choice and avoid high out-of-pocket costs, but the policy produced unintended consequences for the health system and patients. A Commission was convened to first assess the impact of the policy change and provide policy recommendations to the Thai government and, second, provide lessons for countries working to expand equitable access to KRT within national universal health coverage frameworks. Drawing on empirical data, the Commission—composed of Thai and international multidisciplinary experts—employed a structured deliberative process to inform policy interventions. The process and findings underscore the importance of participatory policymaking, underpinned by evidence and a systematic process, and monitoring and evaluation in managing complex policy transitions.


  • Open Access

    A cost- effectiveness and resource requirement comparison to optimize renal dialysis policies in Brunei Darussalam

    by Aye Nandar Myint, Chiao Yuen Lim, Syukri Rahim, Lubna Binti Haji Abdul Razak, Nor Islya Emma Binti Othman, Siobhan Botwright, Waranya Rattanavipapong, Yot Teerawattananon

    Background Chronic kidney disease is a growing global health concern, requiring kidney replacement therapy for survival. In Brunei, kidney failure incidence and prevalence are among the highest globally. Despite a peritoneal dialysis preference policy, uptake remains low, straining financial and human resources. With dialysis costs and demand for skilled healthcare workers projected to rise significantly, this study evaluates the cost effectiveness, budget impact, and human resource requirements of alternative dialysis policies to inform sustainable policy decisions. Methods A Markov model was developed to compare the costs and health outcomes of three policy options under the government and societal perspective: (i) Current Practice, (ii) Automated Peritoneal Dialysis (APD)-first policy, and (iii) Continuous Ambulatory Peritoneal Dialysis (CAPD)-first policy, in which new patients start dialysis with either APD or CAPD respectively unless contraindicated. Budgetary and human resource impacts of each policy were estimated over a five-year period. Results Although both CAPD-first and APD-first policies show improved health and cost savings relative to the current policy, the APD-first policy is dominant (most cost effective) from the societal and government perspectives. Under the current policy, meeting the demand for Hemodialysis (HD) will require an additional 7 nephrologists and 230 HD nurses, whereas the APD and CAPD-first policies will significantly reduce workforce needs over the next 5-year period. Conclusions Findings suggest that Brunei’s current policy is not the most cost-effective or sustainable option. A peritoneal dialysis-first approach could generate significant cost savings and reduce additional demand for scarce nephrologists and dialysis nurses. Our results highlight the need to integrate workforce planning into economic evaluation to inform sustainable dialysis policies.

  • Open Access

    A case study integrating scenario thinking with dialysis policymaking in Thailand

    by Siobhan Botwright, Natcha Yongphiphatwong, Yot Teerawattananon, Jiratorn Sutawong, Kinanti Khansa Chavarina, Tanainan Chuanchaiyakul, John Quigley, Itamar Megiddo, Abigail Colson

    Background Healthcare policymaking often struggles to account for complex future uncertainties, particularly for policies affecting healthcare infrastructure or stakeholder behaviour. Scenario thinking is a structured approach for exploring multiple plausible futures. It has, however, been underutilised in healthcare policymaking. We applied scenario thinking to the 2024 dialysis policy in Thailand to guide policymaking under future uncertainty. Methods Our study is composed of three parts: scenario development, policy analysis, and evaluation of scenario thinking in the policy process. We developed future scenarios using the intuitive logics method, which systematically identifies and explores key uncertainties, and the critical scenario method to evaluate stakeholder responses. Policy options were evaluated for their robustness across future scenarios. We assessed the overall approach according to fitness-for-purpose, influence, and efficiency indicators from established evaluation frameworks for health technology assessment. Results Four scenarios are presented along the dimensions of kidney transplant accessibility and skilled workforce availability. Approval of patients prior to dialysis initiation and a quality monitoring system can strengthen the dialysis programme’s adaptability to future change, while considerable uncertainty exists regarding performance of service provider payment mechanisms. Our evaluation suggests that scenario thinking is an efficient method to characterise future uncertainty within available resources for policymaking. Conclusions This study demonstrates how scenario thinking can systematically evaluate healthcare policies under future uncertainty, providing a framework for more robust policies. Further research is needed to facilitate its use, building on the adaptations developed in this study to bridge scenario thinking with established processes and standards for healthcare policy.


  • Open Access

    Balancing patient choice and health system capacity: a system dynamics model of dialysis in Thailand

    by Siobhan Botwright, Yot Teerawattananon, Jeerath Phannajit, Jiratorn Sutawong, Natcha Yongphiphatwong, Kinanti Khansa Chavarina, John Quigley, Itamar Megiddo, Le Khanh Ngan Nguyen

    As universal health coverage schemes mature, governments often seek to improve patient choice, whilst ensuring that services are appropriate, high-quality, and financially sustainable, especially for high-cost interventions like dialysis. Policy levers to manage supply and demand for services have shown mixed results across contexts, highlighting the complex interactions and feedback effects that shape health system behaviours. Following a policy change in Thailand aiming to improve patient choice for dialysis, we developed a system dynamics model of dialysis demand and supply, to explore the impact of proposed policies on dialysis services whilst accounting for considerable uncertainty in how these policies may work. Model structure was based on a causal loop diagram developed in consultation with stakeholders and iteratively refined through testing, calibration, and validation. The resulting model projected profile of dialysis patients over a 10-year time horizon (2025–2034) under the current policy alongside policy interventions proposed by a working group under the National Health Security Office. We conducted structural and parameter uncertainty analysis to account for uncertainties in the base model and in the mechanisms of action of proposed policy interventions. The model projected that more than one-third of new dialysis patients would inappropriately initiate dialysis under the current policy. None of the proposed policy interventions, either alone or in combination, achieved the defined policy target of 50% new dialysis patients on peritoneal dialysis within 3 years, with a maximum of 45% achieved from combining policies. Performance of all policies decreased over time unless the policy was able to progressively reduce financial incentives paid by private dialysis centres to physicians. Regulating financial incentives in the Thai health system offered the greatest potential to reduce inappropriate dialysis initiation and increase peritoneal dialysis uptake. The system dynamics model showed that coupling policies with complementary mechanisms could address key uncertainties and amplify their impact. We suggest that policymakers incorporate quality of care and time-dependent performance into policy goals to achieve sustainable improvements. Our findings highlight the value of a systems approach to account for unintended consequences of well-intended policy interventions, resulting from delayed responses across organisational boundaries.


  • Open Access

    Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure

    by Siobhan Botwright, Panji Fortuna Hadisoemarto, Kinanti Khansa Chavarina, Aye Nandar Myint, Brandon Wen Bing Chua, Kridsada Chareonrungrueangchai, Chotika Suwanpanich, Pitsinee Supapol, Ijeoma Edoka, Valerie Luyckx, et al.

    Kidney failure is the most advanced stage of chronic kidney disease, at which point patients require kidney replacement therapy (KRT) in the form of kidney transplant or lifelong dialysis to survive. Although many governments seek to provide KRT for patients with kidney failure under publicly funded health schemes, KRT requires considerable financial and human resources, which may need to be diverted from other health programmes. In deciding which KRT services to provide, to whom, and under which conditions, economic evaluation can show the trade-off between the cost and benefit of different policy options. This Guideline has been written for nephrologists, clinicians and policymakers, to build confidence in requesting, contributing towards, and using the results from economic evaluation studies. It is aimed at outlining the cases in which economic evaluation may support KRT policymaking and to lay out good practice for economic evaluation of KRT services. Recommendations cover the process of developing the policy and research questions, conducting the economic evaluation and interpreting results for policy.


  • Top Cited Papers
    Open Access

    Understanding healthcare demand and supply through causal loop diagrams and system archetypes: policy implications for kidney replacement therapy in Thailand

    by Siobhan Botwright, Yot Teerawattananon, Natcha Yongphiphatwong, Jeerath Phannajit, Kinanti Khansa Chavarina, Jiratorn Sutawong, Le Khanh Ngan Nguyen

    Systems thinking approaches can determine system interdependencies to guide effective policymaking but have been underutilised in health policymaking, particularly for policies related to access and delivery of health services. In Thailand, a policy changing access to dialysis services for patients with kidney failure in 2022 had resulted in an unexpected surge in patients, mortality rate, and budget overspend. This study applied systems thinking to characterise the dynamics underlying the unforeseen impact of the 2022 policy, in order to propose context-specific policy interventions. We developed a causal loop diagram through iterative stakeholder engagement, to understand the drivers for supply and demand of dialysis under the 2022 policy in Thailand. Since systems thinking was considered a new tool for policymaking, we used system archetypes as a means by which to collapse down the complexity of causal loop diagrams into simple narratives for policymakers. Confidence-building (validation) was conducted through triangulation across data sources and steps to facilitate stakeholder critique throughout the process. Chronic underinvestment in peritoneal dialysis had failed to capitalise on improvements in expertise and quality of services, while a series of short-term measures to overcome constraints in haemodialysis supply had unintentionally increased haemodialysis demand in the long-term, increasing strain on the healthcare system. By applying generic solution archetypes, we identified a series of measures to balance demand for services with system capacity, including better alignment of incentives with health system goals, proactive planning to anticipate future supply needs, and regulatory mechanisms to moderate demand according to available supply. A major implication of this research is that changes to healthcare access and delivery require multi-stakeholder engagement and whole system thinking, as even small changes can have potentially vast consequences. Applying a systems thinking lens not only communicated the reasons for unintended impact of the 2022 policy, but also identified interventions absent from the literature that were unique to the drivers of demand and supply in Thailand.


  • Open Access

    Durability of the Effectiveness of Heterologous COVID-19 Vaccine Regimens in Thailand: Retrospective Cohort Study Using National Registration Data

    by Ponlagrit Kumwichar, Chittawan Poonsiri, Siobhan Botwright, Natchalaikorn Sirichumroonwit, Bootsakorn Loharjun, Supharerk Thawillarp, Nontawit Cheewaruangroj, Amorn Chokchaisiripakdee, Yot Teerawattananon, Virasakdi Chongsuvivatwong

    Background: The durability of heterologous COVID-19 vaccine effectiveness (VE) has been primarily studied in high-income countries, while evaluation of heterologous vaccine policies in low- and middle-income countries remains limited. Objective: We aimed to evaluate the duration during which the VE of heterologous COVID-19 vaccine regimens in mitigating serious outcomes, specifically severe COVID-19 and death following hospitalization with COVID-19, remains over 50%. Methods: We formed a dynamic cohort by linking records of Thai citizens aged ≥18 years from citizen vital, COVID-19 vaccine, and COVID-19 cases registry databases between May 2021 and July 2022. Encrypted citizen identification numbers were used to merge the data between the databases. This study focuses on 8 common heterologous vaccine sequences: CoronaVac/ChAdOx1, ChAdOx1/BNT162b2, CoronaVac/CoronaVac/ChAdOx1, CoronaVac/ChAdOx1/ChAdOx1, CoronaVac/ChAdOx1/BNT162b2, BBIBP-CorV/BBIBP-CorV/BNT162b2, ChAdOx1/ChAdOx1/BNT162b2, and ChAdOx1/ChAdOx1/mRNA-1273. Nonimmunized individuals were considered for comparisons. The cohort was stratified according to the vaccination status, age, sex, province location, month of vaccination, and outcome. Data analysis employed logistic regression to determine the VE, accounting for potential confounders and durability over time, with data observed over a follow-up period of 7 months. Results: This study includes 52,580,841 individuals, with approximately 17,907,215 and 17,190,975 receiving 2- and 3-dose common heterologous vaccines (not mutually exclusive), respectively. The 2-dose heterologous vaccinations offered approximately 50% VE against severe COVID-19 and death following hospitalization with COVID-19 for 2 months; however, the protection significantly declined over time. The 3-dose heterologous vaccinations sustained over 50% VE against both outcomes for at least 8 months, as determined by logistic regression with durability time-interaction modeling. The vaccine sequence consisting of CoronaVac/CoronaVac/ChAdOx1 demonstrated >80% VE against both outcomes, with no evidence of VE waning. The final monthly measured VE of CoronaVac/CoronaVac/ChAdOx1 against severe COVID-19 and death following hospitalization at 7 months after the last dose was 82% (95% CI 80.3%-84%) and 86.3% (95% CI 83.6%-84%), respectively. Conclusions: In Thailand, within a 7-month observation period, the 2-dose regimens could not maintain a 50% VE against severe and fatal COVID-19 for over 2 months, but all of the 3-dose regimens did. The CoronaVac/CoronaVac/ChAdOx1 regimen showed the best protective effect against severe and fatal COVID-19. The estimated durability of 50% VE for at least 8 months across all 3-dose heterologous COVID-19 vaccine regimens supports the adoption of heterologous prime-boost vaccination strategies, with a primary series of inactivated virus vaccine and boosting with either a viral vector or an mRNA vaccine, to prevent similar pandemics in low- and middle-income countries.